Skip to main content
Top

Advances in Therapy

Issue 10/2024

Content (16 Articles)

Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis

Paschalis Karakasis, Nikolaos Fragakis, Dimitrios Patoulias, Panagiotis Theofilis, George Kassimis, Theodoros Karamitsos, Mohamed El-Tanani, Manfredi Rizzo

Tapering and Sustained Remission of Thrombopoietin Receptor Agonists (TPO-RAs): Is it Time for Paediatric ITP?

Susana Marcos-Peña, Beatriz Fernández-Pernia, Drew Provan, Tomás José González-López

The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review

Luca Potestio, Nello Tommasino, Giuseppe Lauletta, Antonia Salsano, Gioacchino Lucagnano, Luca Menna, Gianluca Esposito, Fabrizio Martora, Matteo Megna

The Economic Burden of Childhood Ocular Morbidity in Bangladesh

  • Open Access
  • Cataract
  • Original Research

A. H. M. Enayet Hussain, Labida Islam, Saidur Rahman Mashreky, Eija Viitasara, Koustuv Dalal

Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons

Walter Reinisch, Gil Y. Melmed, Hiroshi Nakase, Jakob Seidelin, Christopher Ma, Si Xuan, Jacinda Tran, Valencia Remple, Lani Wegrzyn, Gweneth Levy, Yuri Sanchez Gonzalez, Remo Panaccione

Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases

Philip J. Mease, Eros Papademetriou, Ravi Potluri, Ekta Agarwal, Joseph C. Cappelleri, You-Li Ling

Real-World Treatment Persistence Among Advanced Therapy-Naïve or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab

Maryia Zhdanava, Sumesh Kachroo, Porpong Boonmak, Sabree Burbage, Aditi Shah, Jill Korsiak, Patrick Lefebvre, Caroline Kerner, Dominic Pilon

Clinical and Humanistic Burden of Non-inhibitor Haemophilia A in Five European Countries: Insights from the CHESS II Study

Enrico Ferri Grazzi, Tobias Becker, Stephanie Brandt, Gaetan Duport, Daniel-Anibal Garcia Diego, Angelo Lupi, William McKeown, Debra Morgan, Charlotte Camp, Charles Hawes, Tom Blenkiron, Jamie O’Hara, Tom Burke

Inside ANEMIA of CKD: Projecting the Future Burden of Anemia of Chronic Kidney Disease and Benefits of Proactive Management: A Microsimulation Model of the Chinese Population

Lise Retat, Dunming Xiao, Laura Webber, Alexander Martin, Joshua Card-Gowers, Jiaqi Yao, Yuzheng Zhang, Chalet Zhang, Juan Jose Garcia Sanchez, Claudia Cabrera, Susan Grandy, Naveen Rao, Yiqing Wu, Zuo Li, Jianwei Xuan

Real-World Long-Term Persistence and Surgical Procedure-Free Period Among Bio-naïve Patients with Crohn’s Disease and Fistula Initiated on Ustekinumab

Maryia Zhdanava, Sumesh Kachroo, Porpong Boonmak, Sabree Burbage, Aditi Shah, Patrick Lefebvre, Caroline Kerner, Dominic Pilon

Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis

Brett Hauber, Agnes Hong, Elke Hunsche, Martine C. Maculaitis, Sean P. Collins

Real-World Data on Brodalumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: An Observational Study from the Czech Republic BIOREP Registry

Martina Kojanova, Barbora Turkova, Spyridon Gkalpakiotis, Petra Cetkovska, Jorga Fialova, Tomas Dolezal, Alena Machovcova, Eydna Didriksen Apol

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar